PISANO, CHIARA
 Distribuzione geografica
Continente #
NA - Nord America 563
EU - Europa 329
AS - Asia 254
AF - Africa 2
OC - Oceania 2
SA - Sud America 1
Totale 1.151
Nazione #
US - Stati Uniti d'America 552
IT - Italia 107
IE - Irlanda 80
CN - Cina 72
SG - Singapore 68
SE - Svezia 51
IN - India 28
GB - Regno Unito 20
HK - Hong Kong 17
IR - Iran 13
JP - Giappone 13
ES - Italia 12
ID - Indonesia 11
UA - Ucraina 11
KR - Corea 9
CA - Canada 8
CH - Svizzera 7
DE - Germania 7
TR - Turchia 7
CZ - Repubblica Ceca 6
PH - Filippine 6
PL - Polonia 6
NL - Olanda 5
BE - Belgio 4
FR - Francia 4
FI - Finlandia 3
MX - Messico 3
MY - Malesia 3
AT - Austria 2
HU - Ungheria 2
NG - Nigeria 2
VN - Vietnam 2
AE - Emirati Arabi Uniti 1
AM - Armenia 1
AU - Australia 1
BO - Bolivia 1
GR - Grecia 1
HR - Croazia 1
IL - Israele 1
NZ - Nuova Zelanda 1
SA - Arabia Saudita 1
TH - Thailandia 1
Totale 1.151
Città #
Chandler 164
Dublin 80
Singapore 58
Nyköping 37
Turin 35
Medford 17
Santa Clara 16
Princeton 15
Hangzhou 14
Ashburn 13
Seattle 13
Torino 12
Jakarta 11
Chennai 10
Genoa 9
London 9
Beijing 8
Tokyo 8
Fairfield 7
Hong Kong 7
Madrid 7
Moncalieri 7
New York 7
Hebei 6
Los Angeles 6
Milan 6
Seoul 6
Shanghai 6
Wilmington 6
Hyderabad 5
Isfahan 5
Chengdu 4
Guangzhou 4
Montreal 4
Ankara 3
Boston 3
Chicago 3
Coventry 3
Dagupan 3
Liverpool 3
Petaling Jaya 3
Redmond 3
San Diego 3
Vezia 3
Abuja 2
Ann Arbor 2
Barletta 2
Belfast 2
Brno 2
Buffalo 2
Changsha 2
Croydon 2
Dalian 2
Davao City 2
Dearborn 2
Devrek 2
Dong Ket 2
Edmonton 2
Falls Church 2
Gdynia 2
Germantown 2
Ghent 2
Guadalajara 2
Guadix 2
Guiyang 2
Hawthorne 2
Hoover 2
Hradec Králové 2
Istanbul 2
Johnston 2
Kolkata 2
Krakow 2
Lappeenranta 2
Leipzig 2
Maastricht 2
Maniowy 2
Marseille 2
Mumbai 2
Munich 2
Nagytarcsa 2
Nanjing 2
New Delhi 2
Novate Milanese 2
San Marcos 2
Seocho-gu 2
Toronto 2
Trento 2
Woodbridge 2
Wuhan 2
Zurich 2
Adelaide 1
Alessandria 1
Amsterdam 1
Anqing 1
Auckland 1
Austin 1
Bellinzona 1
Birmingham 1
Bonn 1
Brooklyn 1
Totale 754
Nome #
Renal cell carcinoma (RCC): Fatter is better? A review on the role of obesity in RCC 234
Prognostic role of the duration of response to androgen deprivation therapy in patients with metastatic castration resistant prostate cancer treated with enzalutamide or abiraterone acetate 92
Descriptive Comparative Analysis of Patients With Cancer Referring to the Emergency Department of an Italian University Hospital Across the Severe Acute Respiratory Syndrome Coronavirus 2 Waves 64
Antibody-Drug Conjugates in Urothelial Carcinoma: A New Therapeutic Opportunity Moves from Bench to Bedside 62
How far we have come targeting BRAF-mutant non-small cell lung cancer (NSCLC) 55
Oncological Procedures and Risk Assessment of COVID-19 in Thoracic Cancer Patients: A Picture From an Italian Cancer Center 51
Prolonged adrenal insufficiency after the discontinuation of mitotane therapy 49
Bipolar androgen therapy in prostate cancer: Current evidences and future perspectives 48
Management of Oligoprogression in Patients with Metastatic NSCLC Harboring ALK Rearrangements 48
Metastatic Renal Medullary Carcinoma Treated With Immune Checkpoint Inhibitor: Case Report and Literature Review 47
Prognostic factors in metastatic castration resistant prostate cancer patients treated with Radium-223: a retrospective study 46
Immunotherapy in cervix cancer 45
Oligoprogressive Disease With SCLC Transformation in EGFR-Mutated NSCLC: How Biology Knowledge Can Change the Game Rules 44
Role of radium-223 discontinuation due to adverse events in castration-resistant prostate cancer patients. A retrospective monocentric analysis 43
Prognostic role of platelet-to-lymphocyte ratio and neutrophil-to-lymphocyte ratio in patients with metastatic castration resistant prostate cancer treated with Abiraterone or Enzalutamide 42
Metastatic Urothelial Carcinoma: Have We Take the Road to the Personalized Medicine? 39
Treatment intensification for metastatic prostate cancer: New treatment landscapes in androgen deprivation-based therapy 35
Prognostic role of early PSa drop in castration resistant prostate cancer patients treated with abiraterone acetate or enzalutamide 33
Performing oncological procedures during COVID-19 outbreak: a picture from an Italian cancer center 31
Interactions between androgen receptor signaling and other molecular pathways in prostate cancer progression: Current and future clinical implications 31
How to Improve the Quality of Life of Patients with Prostate Cancer Treated with Hormone Therapy? 23
Short-Term Safety and Psychosocial Impact of the BNT162b2 mRNA COVID-19 Vaccine in Cancer Patients-An Italian Single-Center Experience 19
Totale 1.181
Categoria #
all - tutte 6.351
article - articoli 0
book - libri 0
conference - conferenze 265
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 6.616


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20208 0 0 0 1 0 1 1 1 1 1 1 1
2020/202120 0 0 0 0 1 0 2 3 4 2 3 5
2021/2022211 23 5 9 1 7 1 6 4 13 23 68 51
2022/2023577 37 76 16 36 41 112 41 48 70 29 39 32
2023/2024241 29 44 21 30 11 24 10 13 5 19 9 26
2024/2025121 24 57 25 15 0 0 0 0 0 0 0 0
Totale 1.181